NCT05989620
- Conditions
- Cardiomyopathies, Cardiovascular Diseases, Cobblestone Lissencephaly, +70 more
- Locations
-
- Virginia Commonwealth University Richmond, Virginia, United States
Clinical trial condition
Limb-girdle muscular dystrophy, type 2C
Explore clinical trials studying Limb-girdle muscular dystrophy, type 2C. Study availability and eligibility vary by location and protocol.
7 public trials
1 recruiting study
Limb-girdle muscular dystrophy, type 2C trial results
NCT01035983
- Conditions
- Brain Diseases, Central Nervous System Diseases, Headache Disorders, +5 more
- Locations
-
- Munich, Germany
- Budapest, Hungary
- Warsaw, Poland
- Cape Town, South Africa
NCT00786019
- Conditions
- Behavior, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diabetes Mellitus, +16 more
- Locations
-
- University of Colorado Denver Aurora, Colorado, United States
NCT02285062
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Local Institution - 177 Fayetteville, Arkansas, United States
- Local Institution - 136 Orange, California, United States
- Local Institution - 127 Sacramento, California, United States
- Local Institution - 169 New Haven, Connecticut, United States
NCT00785005
- Conditions
- Behavior, Diabetes Mellitus, Diabetes Mellitus, Type 2, +7 more
- Locations
-
- University of Colorado Denver Aurora, Colorado, United States
Completed
Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C
NCT01344798
- Conditions
- Disease Attributes, Gamma-sarcoglycanopathy, Limb Girdle Muscular Dystrophy Type 2C, +6 more
- Locations
-
- Hôpital Pitié-Salpêtrière Paris, France
Active, Not Recruiting
ATA-200 Gene Therapy Trial in Patients With LGMDR5
NCT05973630
- Conditions
- LGMD2C, Limb-girdle muscular dystrophy, type 2C
- Locations
-
- Child Health Research Institute Gainsville, Florida, United States